Ranbaxy Accused Of Filing Deceptive Drug Applications
Michigan-based retailer Meijer Inc. on Tuesday launched a putative class action in Massachusetts federal court accusing Ranbaxy Inc. of recklessly stuffing generic drug approval queues with deceptive applications in an effort...To view the full article, register now.
Already a subscriber? Click here to view full article